Found 181 matching trials
Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali PHASE2 Malaria is a disease that affects many people in Africa. Malaria is caused ...
Show More Location
University of Bamako, Malaria Research and Training Center
Learn More & Join Trial
Vaccine Prevention of Rabies Adopts 4-shot Immunization Method PHASE3 A phase III clinical trial to evaluate the immunogenicity and safety of fre...
Show More Location
Changchun Zhuoyi Biological Co., Ltd
Learn More & Join Trial
Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients NA A single center, prospective cohort, open-label study of rabies post exposu...
Show More Location
Faculty of Medicine, Siriraj Hospital, Mahidol University
Learn More & Join Trial
Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults PHASE3 The primary objective of this study is:
To demonstrate the VRVg-2 is non-i...
Show More Location
Investigational Site Number : 7640001
Learn More & Join Trial
Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib PHASE1 P27A study is designed as a randomized phase Ia/Ib trial to evaluate the sa...
Show More Learn More & Join Trial
Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure Regimen N/A This study will evaluate the immunogenicity of rabies vaccine at 13 months,...
Show More Location
Multiple Locations
Learn More & Join Trial
Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine PHASE1 The purpose of this study is to evaluate the safety of sIPVs of different d...
Show More Location
Pizhou City Center for Disease Control and Prevention
Learn More & Join Trial
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B PHASE1 The purpose of this study is to determine whether an investigational malari...
Show More Location
Multiple Locations
Learn More & Join Trial
An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa PHASE3 The purpose of this study is to conduct long-term surveillance for efficacy...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali PHASE1 Background:
Researchers are trying to develop a vaccine that will safely r...
Show More Location
Malaria Research Training Center
Learn More & Join Trial